Brand Name : Mycomune-s
Composition : Mycophenolate Mofetil
Strength availability : 360mg
Manufactured by : Zydus Cadila
Tab Count : 10 Tablets in 1 strip

Mycophenolic acid is belonging to immunosuppressive drug. Mycomune-s 360mg is an inactive form of mycophenolic acid (MPA). Following oral administration, Mycomune-s 360mg is fastly absorbed and hydrolysed change into MPA. MPA is the effective metabolite which has pharmacological action.
Mycomune-s 360mg which is used as prescription drug provided under the guidance of doctors.


Mycomune-s 360mg is an immunosuppressant drug which is;
Prescribed for the prophylaxis of organ refusal in patients getting allogeneic renal, cardiac or hepatic transplants.


Mycomune-s is primarily nec essary for inhibition of organ transplant of kidney, heart and liver, the dosage as follows
Kidney transplantation :
For Adult the recommended dose for kidney transplantation is 1 g given orally or intravenously (over no less than 2 hours) twice a day.
For paediatric (3 months to 18 years of age) the recommended dose of the oral suspension is 600 mg/m2 given twice daily (maximum daily dose of 2 g/10 ml).
Dosage also calculated according to body surface area :
Capsule dose of 750 mg twice daily administers to Patients with a body surface area of 1.25 m2 to 1.5 m2.
Capsules or tablets at a 1 g dose twice daily is administrated to Patients with a body surface area >1.5 m2.
Heart transplantation :
For Adults the prescribed dose for heart transplantation is 1.5 g given twice daily intravenously over no less than 2 hours or 1.5 g administrated orally twice daily.
Liver Transplantation :
For Adults the prescribed dose for Liver Transplantation is 1 g twice daily given via intravenously over no less than 2 hours or 1.5 g orally twice daily.
For Geriatrics (elderly patients) the recommended orally is 1 g dose twice daily for renal transplant patients, 1.5 g dose
given twice daily for heart transplant patients, and 1 g dose twice in a day administered intravenously or 1.5 g dose twice in a day given orally in liver transplant patients.


Mycophenolate Mofetil consist of morpholino ethyl ester of mycophenolic acid (MPA) with effective immunosuppressive properties mycophenolic blocks T-cell and B-cell multiplication via selective prohibition of the de novo pathway of purine biosynthesis. In vivo, the effective metabolite, MPA, reversibly prevents inosine 5’-monophosphate dehydrogenase, an enzyme contains in the de novo synthesis of guanine nucleotides. MPA show high lymphocyte specificity and cytotoxicity because of higher dependence of stimulation lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04).


Rapidly absorbed and bioavailability are 94% for oral Mycophenolate mofetil
the active metabolite MPA bounded to plasma protein is 98%.
Primarily metabolised by glucuronic transferase to form inactive phenolic glucuronide of MPA.
Mycomune-s 360mg is totally recovered with 93% dose in urine and 6% via feces and 87% administrated dose eliminated via urine as MPAG
Half-life of Mycomune-s is 13-17 hours


Embryofoetal Toxicity :
Mycomune-s 360mg can leads foetal harm when given to a pregnant female. While Use of Mycomune-s during pregnancy is along with an high risk of first trimester pregnancy loss and increased risk of congenital malformations
Lymphoma and Malignancy :
When Patients getting immunosuppressive drug including co administration of drugs, contains Mycomune-s 360mg, as part of an immunosuppressive regimen have increase of developing lymphomas and other malignancies, especially effect the skin
Pregnancy Exposure Prevention and Planning :
Females of reproductive possible should be made aware of the high risk of lack of first trimester pregnancy and congenital malformations and must be advise about pregnancy stopping and planning.


Concomitant use of Mycomune-s 360mg with acyclovir or ganciclovir may causes high blood levels Mycomune-s and interacting drugs elimination through kidneys the drugs complete with each other
Mycomune-s 360mg concomitant use with antacid may reduce MPA blood levels
Combination with proton pump may reduce blood levels by binding in the intestine.
Mycomune-s 360mg concomitant use with birth control pills may reduce the effectiveness of some oral contraceptives


Mycomune-s 360mg is contraindicated to the patients having with;
Hypersensitivity to mycophenolate mofetil
Allergic to polysorbate 80 (tween)
Pregnant women
Breastfeeding women


If dose is not taken, have immediately before next dose reaches or skip the dose and follow normal timing Please Consult with the doctor


Mycomune-s 360mg is stored at 25℃
Protect drug in a tight, light resistant container.


Mycomune-s 360mg Common side effects :
Abdominal pain
Swelling of the ankles or feet, lower legs
Serious side effects :
Infection in blood
Low RBC, and WBC

We'd Like to Hear From You!


1., a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
2. will not dispense any prescription medication without a valid prescription from a licensed physician.
3. If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.
4. The drug information provided in the is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
5. requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from
6. At, a Caregiver can order prescription medicines on your behalf.

This information should not be used to decide whether to accept this product or any other medicine. Only a health care provider is knowledge and training to decide that a medicine suitable for a specific patient. This information does not support any drug as safe, are effective or approved for the treatment of any patient or health condition. It's simple a brief overview of general information about this product. It does not include all information on possible applications, indications, warnings, precautions, interactions, adverse effects or risks that may be relevant to this product. This information is not specific medical advice and does not replace information obtained from your health care provider. You should check with your health care provider for complete information about the risks and benefits of using this product.